LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 6 of 15: Mean cell count and mean growth rate across biological replicate 3. - Dataset (ID:20242)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
BT-20 | Selumetinib | 0.37 | uM | LJP6 | 72 | hr | 1097 | 3537 | 3769 | 0.9385 | 0.9132 |
BT-20 | Sirolimus | 0.37 | uM | LJP6 | 72 | hr | 1097 | 2186 | 3769 | 0.5800 | 0.4076 |
BT-20 | Sorafenib | 0.37 | uM | LJP6 | 72 | hr | 1097 | 3050 | 3769 | 0.8091 | 0.7307 |
BT-20 | SU11274 | 0.37 | uM | LJP5 | 72 | hr | 1097 | 3913 | 3769 | 1.0381 | 1.0538 |
BT-20 | Fedratinib | 0.37 | uM | LJP5 | 72 | hr | 1097 | 3539 | 3769 | 0.9388 | 0.9137 |
BT-20 | TGX221 | 0.37 | uM | LJP5 | 72 | hr | 1097 | 3823 | 3769 | 1.0143 | 1.0201 |
BT-20 | Torin1 | 0.37 | uM | LJP6 | 72 | hr | 1097 | 1006 | 3769 | 0.2669 | -0.0341 |
BT-20 | Torin2 | 0.37 | uM | LJP5 | 72 | hr | 1097 | 771 | 3769 | 0.2046 | -0.1220 |
BT-20 | Tozasertib | 0.37 | uM | LJP5 | 72 | hr | 1097 | 1196 | 3769 | 0.3173 | 0.0370 |
BT-20 | Trametinib | 0.37 | uM | LJP5 | 72 | hr | 1097 | 2861 | 3769 | 0.7591 | 0.6601 |
BT-20 | TWS119 | 0.37 | uM | LJP5 | 72 | hr | 1097 | 3565 | 3769 | 0.9458 | 0.9236 |
BT-20 | Vemurafenib | 0.37 | uM | LJP5 | 72 | hr | 1097 | 3582 | 3769 | 0.9504 | 0.9301 |
BT-20 | Withaferin A | 0.37 | uM | LJP5 | 72 | hr | 1097 | 2794 | 3769 | 0.7414 | 0.6352 |
BT-20 | Withaferin A | 0.37 | uM | LJP6 | 72 | hr | 1097 | 2260 | 3769 | 0.5996 | 0.4352 |
BT-20 | WYE-125132 | 0.37 | uM | LJP6 | 72 | hr | 1097 | 1319 | 3769 | 0.3501 | 0.0832 |
BT-20 | WZ3105 | 0.37 | uM | LJP5 | 72 | hr | 1097 | 1143 | 3769 | 0.3032 | 0.0171 |
BT-20 | XMD11-50 | 0.37 | uM | LJP6 | 72 | hr | 1097 | 2621 | 3769 | 0.6953 | 0.5702 |
BT-20 | Y39983 | 0.37 | uM | LJP6 | 72 | hr | 1097 | 3468 | 3769 | 0.9202 | 0.8874 |
BT-20 | YM 201636 | 0.37 | uM | LJP5 | 72 | hr | 1097 | 3692 | 3769 | 0.9796 | 0.9712 |
BT-20 | ZSTK474 | 0.37 | uM | LJP6 | 72 | hr | 1097 | 1979 | 3769 | 0.5250 | 0.3300 |
BT-20 | Afatinib | 1.11 | uM | LJP6 | 72 | hr | 1097 | 3152 | 3769 | 0.8364 | 0.7692 |
BT-20 | Sigma A6730 | 1.11 | uM | LJP5 | 72 | hr | 1097 | 3335 | 3769 | 0.8849 | 0.8376 |
BT-20 | Alvocidib | 1.11 | uM | LJP6 | 72 | hr | 1097 | 612 | 3769 | 0.1624 | -0.1816 |
BT-20 | AT-7519 | 1.11 | uM | LJP6 | 72 | hr | 1097 | 588 | 3769 | 0.1560 | -0.1906 |
BT-20 | AZD 5438 | 1.11 | uM | LJP6 | 72 | hr | 1097 | 1022 | 3769 | 0.2712 | -0.0280 |